Informations générales (source: ClinicalTrials.gov)

NCT05431738 En recrutement IDF
Esophageal Stent With or Without Anti-migration Device for Tumors of the Gastroesophageal Junction: Multicenter Randomized Controlled Study. ANTIMIG Study (ANTIMIG)
Interventional
N/A
Société Française d'Endoscopie Digestive (Voir sur ClinicalTrials)
septembre 2022
septembre 2025
31 juillet 2024
The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.
 Voir le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
CLCC INSTITUT GUSTAVE ROUSSY Hichem BELKHODJA En recrutement IDF 26/02/2024 10:57:49  Contacter
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
French Society of Digestive Endoscopy - 75006 - Paris - France David KARSENTI, MD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

1. Patient of both sexes aged 18 or over.

2. Patient admitted to one of the investigation centers for dysphagia due to tumoral
stenosis of the gastroesophageal junction, locally advanced or metastatic.

3. Patient ASA 1, ASA 2, ASA 3

4. Absence of participation in another clinical study

5. Signed Informed Consent

6. Patients benefiting from the social security system.


1. Patient referred for stenosis by extrinsic compression by an extra digestive mass

2. Patients with contraindications relating to the procedures essential for the
introduction of a stent

3. Mediastinal radiotherapy or esophageal surgery history

4. Patient under 18 or over 90

5. Patient ASA 4, ASA 5

6. Pregnant Woman

7. Patient unable to give personal consent

8. Absence of signed informed consent